Senior Director, US New Product Planning (ADPKD Lead)

Job Description

General Summary:

We are seeking a Senior Director, US New Product Planning to help shape the future of our pipeline and build the foundation for successful US launches within an expanding and highly visible Business Unit. This is a high-impact leadership role for a strategic, commercially minded, and pragmatic leader who thrives at the intersection of asset strategy, US market planning, launch readiness, and Business Unit build-out.

This role is ideal for someone who has worked in both the US business and on global teams, and who understands what it takes to succeed in the US market across functions—not just within a single discipline. The individual will represent the US perspective for early pipeline assets, including assets approximately 3-4 years from launch, and help ensure that strategic decisions made today translate into successful launches tomorrow.

Importantly, this role offers the opportunity to help build and expand a new Business Unit for the organization. As the pipeline advances, this leader will help define the commercial foundation, capability needs, operating model, resourcing approach, and organizational priorities required to bring new assets into an expanding, strategically important, and highly visible BU.

Key Responsibilities

• Represent the US commercial perspective on global asset teams for early pipeline assets, especially those approximately 4 years from launch
• Lead development of US commercial strategy in partnership with global commercial, medical, market access, HEOR, analytics, operations, and finance
• Translate asset strategy into a clear US launch blueprint, including:
  • market development priorities
  • launch scenarios and key assumptions
  • capability requirements
  • organization design implications
  • field force and non-personal promotion considerations
  • budget and investment needs
• Identify and frame key strategic choices related to:
  • positioning
  • patient finding and market development
  • access and reimbursement readiness
  • evidence generation priorities
  • customer engagement model
  • patient services and support strategy
• Develop milestone-based and scenario-based plans that prepare the organization for launch well before traditional pre-launch planning begins
• Partner with cross-functional leaders to define the capabilities, talent, processes, and infrastructure needed for launch success
• Help shape the Business Unit growth strategy by defining what is needed to successfully absorb and commercialize new assets within an expanding BU
• Provide strategic input on US commercialization models, including implications for specialty, and  institution-based markets
• Support governance and executive decision-making with clear recommendations, tradeoffs, and risk assessments
• Help ensure a smooth transition from early planning into launch readiness and in-market execution
• Help define the strategic and organizational foundations of a growing, high-profile Business Unit

Required Experience

• Significant experience in biotech or pharmaceutical commercial strategy, new product planning, marketing, launch strategy, or related roles
• Meaningful experience in both:
  • US commercial/business roles
  • Global or enterprise asset/team roles
• Demonstrated success in new product planning, pre-launch strategy, or launch planning
• Deep experience in hematology and/or rare disease
• Strong understanding of US commercialization in complex specialty markets, and related access, site-of-care, and reimbursement considerations
• Proven ability to help build or scale commercial infrastructure for new assets entering an expanding Business Unit
• Experience building or shaping resourcing plans, operating models, and capability roadmaps
• Proven ability to influence senior stakeholders and lead through a matrixed environment
• Strong track record of cross-functional collaboration across commercial, medical, market access, analytics, operations, finance, and patient services

Preferred Experience

• Experience in US commercial planning, brand leadership, or business leadership
• Experience serving on a global asset team or in a global commercial strategy role
• Experience in hematology, specialty markets, and complex launch environments
• Experience supporting assets from development through launch readiness
• Experience helping establish or expand a new or emerging Business Unit, franchise, or therapeutic area organization

Critical Capabilities

• Enterprise thinking — sees beyond function and understands the full set of enablers required for US launch success
• US market insight — understands customer, access, evidence, reimbursement, and operational realities in the US
• Cross-functional integration — connects perspectives across teams to create practical, aligned plans
• Launch planning excellence — translates strategic choices into launch milestones, readiness plans, and execution requirements
• Organizational and capability planning — defines what talent, structure, and capabilities will be needed over time
• Business Unit building — understands how to establish the strategic, organizational, and operational foundations needed to bring new assets into an expanding BU
• Executive communication — distills complexity into clear, compelling recommendations
• Pragmatic decision-making — operates effectively under uncertainty and turns ambiguity into action

Why This Role Stands Out

This is a unique opportunity to influence some of the most important decisions in the pipeline—before launch planning is fully formed and while strategic choices can still shape outcomes.

You will have the chance to:

• shape the future of the US business
• influence asset strategy at an early stage
• work across US and global leadership
• define how the organization prepares for future launches
• help build and scale an expanding, highly visible Business Unit
• bring both strategic rigor and practical judgment to high-impact decisions
• play a central role in how new assets are introduced into a strategically important growth area for the company

Success in This Role Looks Like

• The US perspective is incorporated early and meaningfully into asset strategy
• Strategic choices are translated into actionable US launch and capability plans
• Leadership has clear visibility into risks, tradeoffs, and investment needs
• The organization is better prepared for launch—earlier, more thoughtfully, and with greater alignment
• Cross-functional teams are aligned around a practical path to US success
• New assets are positioned to enter an expanding and highly visible Business Unit with the right strategic foundation, capabilities, and operating model in place

Pay Range:

Disclosure Statement:

Flex Designation:

Flex Eligibility Status:

In this Hybrid-Eligible role, you can choose to be designated as: 
1.    Hybrid: work remotely up to two days per week; or select
2.    On-Site: work five days per week on-site with ad hoc flexibility.

Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time. 

#LI-Hybrid
 

Company Information

Vertex is a global biotechnology company that invests in scientific innovation.

Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at [email protected]